-
My Account
In App
My Account
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 149 | 179.00 | 179.30 | 322 |
| 322 | 178.90 | 179.35 | 139 |
| 122 | 178.85 | 179.50 | 514 |
| 400 | 178.80 | 179.65 | 400 |
| 1535 | 178.50 | 179.75 | 4 |
| 0 | Total | Total | 0 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 149 | 179.00 | 179.30 | 322 |
| 322 | 178.90 | 179.35 | 139 |
| 122 | 178.85 | 179.50 | 514 |
| 400 | 178.80 | 179.65 | 400 |
| 1535 | 178.50 | 179.75 | 4 |
| 0 | Total | Total | 0 |
As on --
(OI , PRICE )
As on --
| Open | 179.20 |
| Previous Close | 178.48 |
| Volume | 5,009,603.00 |
| Value (Lacs) | 8,960.18 |
| VWAP | 0.00 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 23,775 |
| High | 182.93 |
| Low | 177.98 |
| UC Limit | 0.00 |
| LC Limit | 0.00 |
| 52 Week High | 255.65 |
| 52 Week Low | 165.12 |
| Face Value | 10.00 |
| All Time High | 307.90 |
| All Time Low | 0.00 |
| 20D Avg Volume | 4,236,915 |
| 20D Avg Delivery(%) | 33.80 |
| Book Value Per Share | 60.77 |
| Dividend Yield | 0.08 |
| TTM EPS See historical trend | -0.18 |
| TTM PE See historical trend | -- (Low PE) |
| P/B See historical trend | 2.94 (Average P/B) |
| Sector PE | 39.86 |
*Delayed by 20 seconds.
Stock Score
Get detailed analysis with Moneycontrol Stock Insights.
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
2 out of 4 years Piramal Pharma has given negative returns in January.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| January | 3.89% (2024) | 3.89% | -12.53% (2025) | -10.49% | -5.70% |
Buy Piramal Pharma; target of Rs 240: Motilal Oswal Nov 12 2025 03:41 PM
Piramal Pharma Standalone September 2025 Net Sales at Rs 1,127.26 crore, down 12.23% Y-o-Y Nov 12 2025 10:01 AM
Piramal Pharma Consolidated September 2025 Net Sales at Rs 2,043.72 crore, down 8.83% Y-o-Y Nov 06 2025 11:13 AM
Piramal Pharma posts Rs 99 crore loss in Q2FY26 weighed down by CDMO business Nov 05 2025 10:44 PM
happy to see the move. it is a long time waiting i stuck at 210 View more
Posted by : sunsil
General observations raised by FDA which every company rectifies. operators r grabbing for 220 target. I feel one can buy at this level for 20 percent upside in short term hopefully.consult experts View more
Posted by : BBS18
Posted by : The Fixed Income
Repost this message
A new Senior Secured Bond Opportunity is opening soon. Earn fixed returns of up to 8.90% with the Adani Enterprises Bond Public Issue, opening on 6th January 2026. Rated AA- (Stable) by CARE & ICRA, this senior secured bond offers stability with a minimum investment of just ₹10,000. Pre-book now and lock in predictable income from a high-quality issuer : https://www.thefixedincome.com/product/IPO-details/dXhhdQ-tfi/adani-enterprises-limited?utm_source=Moneycontrol&utm_medium=MCForum&utm_campaign=product_list
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 6856958 | Price 219.7 | % Traded 0.52 |
| Qty 6856958 | Price 219.88 | % Traded 0.52 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
